Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
NervGen Pharma Corp. Common stock
Market Cap
$147.54M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$147.49M
EBITDA Margin
-239.78%
TTM Avg
-210.59%
3Y Avg
-2213.91%
5Y Avg
-2345.87%
Market Cap
$147.97M
EBITDA Margin
-0.19%
TTM Avg
-1.66%
3Y Avg
-11.02%
5Y Avg
-42.72%
Market Cap
$146.30M
EBITDA Margin
-16238.30%
TTM Avg
-8929.91%
3Y Avg
-4730.54%
5Y Avg
-4730.54%
Market Cap
$150.59M
EBITDA Margin
-550.97%
TTM Avg
-275.49%
3Y Avg
-275.49%
5Y Avg
-275.49%
Market Cap
$143.10M
EBITDA Margin
-783.01%
TTM Avg
-1033.45%
3Y Avg
-1010.27%
5Y Avg
-3715.70%
Market Cap
$152.26M
EBITDA Margin
-47.00%
TTM Avg
-68.63%
3Y Avg
-61.93%
5Y Avg
-48.63%
Market Cap
$142.15M
EBITDA Margin
5.24%
TTM Avg
5.41%
3Y Avg
5.74%
5Y Avg
10.79%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NervGen Pharma Corp. Common stock (NGEN) | $147.54M | N/A | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $147.49M | -239.78% | -210.59% | -2213.91% | -2345.87% |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | -0.19% | -1.66% | -11.02% | -42.72% |
| Immuneering Corporation (IMRX)vs › | $146.30M | -16238.30% | -8929.91% | -4730.54% | -4730.54% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $150.59M | -550.97% | -275.49% | -275.49% | -275.49% |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -783.01% | -1033.45% | -1010.27% | -3715.70% |
| Codexis, Inc. (CDXS)vs › | $152.26M | -47.00% | -68.63% | -61.93% | -48.63% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $142.15M | 5.24% | 5.41% | 5.74% | 10.79% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $154.46M | -48812.58% | -48812.58% | -48812.58% | -48812.58% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
